Peptides and Longevity: Redefining Aging and Transforming Health with Dr. Kent Holtorf

Publicly listed emails

paulb@holtorfmed.com

Looking for the right person? Join Podseeker to find direct host and producer contacts and manage your podcast outreach.

Unlock the Secrets to Longevity and Chronic Illness With 3rd Generation Oral Peptides

September 09, 2026

I keep coming back to one idea in this talk: the immune system is not a side character in aging and chronic illness—it is closer to the director. I lay out the teeter-totter first: the TH1 and regulatory side against the TH2 and TH17 side, and how the thymus winding down from childhood on quietly shifts that balance until an aged immune phenotype takes over. From there, the dominoes are familiar to anyone who works with complex patients: hypothalamic and pituitary hormone dysfunction, mitocho...

Breakthroughs in Longevity Science and Aesthetics from the Inside Out with Oral Peptide Bioregulators

August 26, 2026

I did not plan to give this talk. I arrived at the AIMS Symposium, realized how much of the room was aesthetics, and did not have a single slide on the oral skin bioregulators we have been working on for years. So I rebuilt it. What is happening in that room is worth paying attention to, because beauty and functional medicine are being pushed together and nobody has decided yet whether the plastic surgeons, the regenerative doctors, the orthomolecular people or the naturopaths end up owning i...

A Multi System Treatment Approach to Traumatic Brain Injury, PTSD & Neurodegenerative Disease Using Peptides

August 13, 2026

A head injury does not stay in the head. In this episode of Peptides and Longevity, I share the talk I gave for Boston BioLife on treating traumatic brain injury, post-traumatic stress, and neurodegenerative disease as one connected problem instead of three separate ones. I walk through why the blood-brain barrier and the gut open at the same moment, how the immune system shifts and pulls mitochondria, hormones, and mast cells down with it, and which peptides I reach for first when a patient ...